Institutional Ownership Xilio Therapeutics, Inc. (XLO)
This table provides information about the institutional ownership of Xilio Therapeutics, Inc. (XLO). We have compiled data on the 33 institutions that hold shares in the stock, with a total of 12.6 Million shares, which have been reported (via 13F filing form) to have a value of $9.42 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Adar1 Capital Management, LLC
Austin, TX |
Aug 13, 2024 Q2 2024 |
1,500
shares
|
$1,125
0.0% of portfolio
|
Q2 2024
New holding
|
|
Key F Inancial Inc
|
Jul 29, 2024 Q2 2024 |
830
shares
|
$622
0.0% of portfolio
|
Q1 2023
New holding
|
|
Bank Of America Corp
Charlotte, NC |
Aug 14, 2024 Q2 2024 |
692
shares
|
$519
0.0% of portfolio
|
Q2 2024
New holding
|
|
Royal Bank Of Canada
Toronto, A6 |
Aug 14, 2024 Q2 2024 |
366
shares
|
$274
0.0% of portfolio
|
Q2 2024
Reduced 31.33%
|
|
Ubs Group Ag
|
Aug 13, 2024 Q2 2024 |
201
shares
|
$150
0.0% of portfolio
|
Q3 2022
Reduced 92.86%
|
|
Jpmorgan Chase & CO
New York, NY |
Aug 12, 2024 Q2 2024 |
59
shares
|
$44
0.0% of portfolio
|
Q2 2024
Reduced 97.85%
|
|
Qube Research & Technologies LTD
London, X0 |
Aug 14, 2024 Q2 2024 |
4
shares
|
$3
0.0% of portfolio
|
Q3 2023
New holding
|
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
Jul 23, 2024 Q2 2024 |
0
shares
|
$0
0.0% of portfolio
|
Q2 2024
New holding
|